Ogawa Kohei, Shinjo Daisuke, Suzuki Tomo, Azuma Hiromitsu, Wada Seiji, Fushimi Kiyohide
Center for Maternal-Fetal, Neonatal and Reproductive Medicine, National Center for Child Health and Development, 2-10-1 Okura, Setagaya-ku, Tokyo , 157-8535, Japan.
Department of Health Policy and Informatics, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Sci Rep. 2025 Jul 2;15(1):22633. doi: 10.1038/s41598-025-07530-4.
In Japan, maintenance tocolysis has been conventionally administered. The current study aimed to identify the annual trends in the prolonged administration of ritodrine hydrochloride and its differences in terms of region and type of facility. This study used data from the Japanese Diagnosis Procedure Combination inpatient database, and the survey included women with premature labor or threatened premature delivery based on the International Statistical Classification of Diseases and Related Health Problems, 10th Revision, codes. The primary outcome was prolonged administration of ritodrine hydrochloride, defined as treatment for ≥ 4 days. The primary exposures were type of institution, regions where the institutions are located, and year at admission. The effect of each exposure on prolonged administration was assessed via multivariate-modified Poisson regression analysis. Of 280,734 female participants, 180,674 received prolonged administration of ritodrine hydrochloride. Women in primary hospitals had a significantly more prolonged duration of administration than those in tertiary hospitals. Prolonged administration was significantly more common in Hokkaido, Chubu, Kansai, and Shikoku than in Tokyo. Conversely, Kyushu had a significantly lower adusted risk ratio than Tokyo. The prolonged administration of ritodrine hydrochloride has been gradually decreasing annually. However, the rate differed in terms of regions and type of facility.
在日本,维持性tocolysis一直是常规治疗方法。本研究旨在确定盐酸利托君长期给药的年度趋势及其在地区和医疗机构类型方面的差异。本研究使用了日本诊断程序组合住院患者数据库的数据,调查对象包括根据《国际疾病分类及相关健康问题统计分类》第10版编码诊断为早产或先兆早产的女性。主要结局是盐酸利托君的长期给药,定义为治疗≥4天。主要暴露因素为机构类型、机构所在地区和入院年份。通过多变量修正泊松回归分析评估每种暴露因素对长期给药的影响。在280,734名女性参与者中,180,674人接受了盐酸利托君的长期给药。基层医院的女性给药时间明显长于三级医院。北海道、中部、关西和四国地区的长期给药明显比东京更常见。相反,九州的调整风险比明显低于东京。盐酸利托君的长期给药每年逐渐减少。然而,不同地区和医疗机构类型的减少率有所不同。